Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.
2.

Rosiglitazone inhibits angiotensin II-induced CTGF expression in vascular smooth muscle cells - role of PPAR-gamma in vascular fibrosis.

Gao DF, Niu XL, Hao GH, Peng N, Wei J, Ning N, Wang NP.

Biochem Pharmacol. 2007 Jan 15;73(2):185-97. Epub 2006 Sep 23.

PMID:
17074304
3.

Long-chain acyl-CoA synthetase 4 modulates prostaglandin E₂ release from human arterial smooth muscle cells.

Golej DL, Askari B, Kramer F, Barnhart S, Vivekanandan-Giri A, Pennathur S, Bornfeldt KE.

J Lipid Res. 2011 Apr;52(4):782-93. doi: 10.1194/jlr.M013292. Epub 2011 Jan 17.

4.

Distinct transcriptional regulation of long-chain acyl-CoA synthetase isoforms and cytosolic thioesterase 1 in the rodent heart by fatty acids and insulin.

Durgan DJ, Smith JK, Hotze MA, Egbejimi O, Cuthbert KD, Zaha VG, Dyck JR, Abel ED, Young ME.

Am J Physiol Heart Circ Physiol. 2006 Jun;290(6):H2480-97. Epub 2006 Jan 20.

5.

Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells.

Mashek DG, McKenzie MA, Van Horn CG, Coleman RA.

J Biol Chem. 2006 Jan 13;281(2):945-50. Epub 2005 Nov 1.

6.

Role of long-chain acyl-CoA synthetase 4 in formation of polyunsaturated lipid species in hepatic stellate cells.

Tuohetahuntila M, Spee B, Kruitwagen HS, Wubbolts R, Brouwers JF, van de Lest CH, Molenaar MR, Houweling M, Helms JB, Vaandrager AB.

Biochim Biophys Acta. 2015 Feb;1851(2):220-30. doi: 10.1016/j.bbalip.2014.12.003. Epub 2014 Dec 9.

PMID:
25500141
7.

Characterization of recombinant long-chain rat acyl-CoA synthetase isoforms 3 and 6: identification of a novel variant of isoform 6.

Van Horn CG, Caviglia JM, Li LO, Wang S, Granger DA, Coleman RA.

Biochemistry. 2005 Feb 8;44(5):1635-42.

PMID:
15683247
8.

Sex dimorphic actions of rosiglitazone in generalised peroxisome proliferator-activated receptor-gamma (PPAR-gamma)-deficient mice.

Duan SZ, Usher MG, Foley EL 4th, Milstone DS, Brosius FC 3rd, Mortensen RM.

Diabetologia. 2010 Jul;53(7):1493-505. doi: 10.1007/s00125-010-1748-2. Epub 2010 Apr 17. Erratum in: Diabetologia. 2012 Jan;55(1):270-1.

9.

Activation of peroxisome proliferator-activated receptor-γ by rosiglitazone improves lipid homeostasis at the adipose tissue-liver axis in ethanol-fed mice.

Sun X, Tang Y, Tan X, Li Q, Zhong W, Sun X, Jia W, McClain CJ, Zhou Z.

Am J Physiol Gastrointest Liver Physiol. 2012 Mar 1;302(5):G548-57. doi: 10.1152/ajpgi.00342.2011. Epub 2011 Dec 15.

10.

Genes involved in fatty acid partitioning and binding, lipolysis, monocyte/macrophage recruitment, and inflammation are overexpressed in the human fatty liver of insulin-resistant subjects.

Westerbacka J, Kolak M, Kiviluoto T, Arkkila P, Sirén J, Hamsten A, Fisher RM, Yki-Järvinen H.

Diabetes. 2007 Nov;56(11):2759-65. Epub 2007 Aug 17.

11.

The macrophage-mediated effects of the peroxisome proliferator-activated receptor-gamma agonist rosiglitazone attenuate tactile allodynia in the early phase of neuropathic pain development.

Takahashi Y, Hasegawa-Moriyama M, Sakurai T, Inada E.

Anesth Analg. 2011 Aug;113(2):398-404. doi: 10.1213/ANE.0b013e31821b220c. Epub 2011 Apr 13.

PMID:
21490083
12.

Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.

Klett EL, Chen S, Edin ML, Li LO, Ilkayeva O, Zeldin DC, Newgard CB, Coleman RA.

J Biol Chem. 2013 Jul 26;288(30):21618-29. doi: 10.1074/jbc.M113.481077. Epub 2013 Jun 13.

13.

PPAR-gamma response element activity in intact primary human adipocytes: effects of fatty acids.

Sauma L, Stenkula KG, Kjølhede P, Strålfors P, Söderström M, Nystrom FH.

Nutrition. 2006 Jan;22(1):60-8. Epub 2005 Oct 12.

PMID:
16226011
14.

Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.

Chakrabarti R, Misra P, Vikramadithyan RK, Premkumar M, Hiriyan J, Datla SR, Damarla RK, Suresh J, Rajagopalan R.

Eur J Pharmacol. 2004 May 3;491(2-3):195-206.

PMID:
15140637
15.

Lipid synthesis in macrophages during inflammation in vivo: effect of agonists of peroxisome proliferator activated receptors alpha and gamma and of retinoid X receptors.

Posokhova EN, Khoshchenko OM, Chasovskikh MI, Pivovarova EN, Dushkin MI.

Biochemistry (Mosc). 2008 Mar;73(3):296-304.

PMID:
18393765
16.

Saturated non-esterified fatty acids stimulate de novo diacylglycerol synthesis and protein kinase c activity in cultured aortic smooth muscle cells.

Yu HY, Inoguchi T, Kakimoto M, Nakashima N, Imamura M, Hashimoto T, Umeda F, Nawata H.

Diabetologia. 2001 May;44(5):614-20.

PMID:
11380080
17.

Peroxisome proliferator-activated receptor gamma activation promotes infiltration of alternatively activated macrophages into adipose tissue.

Stienstra R, Duval C, Keshtkar S, van der Laak J, Kersten S, Müller M.

J Biol Chem. 2008 Aug 15;283(33):22620-7. doi: 10.1074/jbc.M710314200. Epub 2008 Jun 9.

18.

Early atheroma-derived agonists of peroxisome proliferator-activated receptor-γ trigger intramedial angiogenesis in a smooth muscle cell-dependent manner.

Ho-Tin-Noé B, Le Dall J, Gomez D, Louedec L, Vranckx R, El-Bouchtaoui M, Legrès L, Meilhac O, Michel JB.

Circ Res. 2011 Oct 14;109(9):1003-14. doi: 10.1161/CIRCRESAHA.110.235390. Epub 2011 Sep 1.

19.
20.

Rosiglitazone increases indexes of stearoyl-CoA desaturase activity in humans: link to insulin sensitization and the role of dominant-negative mutation in peroxisome proliferator-activated receptor-gamma.

Risérus U, Tan GD, Fielding BA, Neville MJ, Currie J, Savage DB, Chatterjee VK, Frayn KN, O'Rahilly S, Karpe F.

Diabetes. 2005 May;54(5):1379-84.

Supplemental Content

Support Center